| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3190651 | Annals of Allergy, Asthma & Immunology | 2016 | 6 Pages |
Abstract
Fluticasone furoate-vilanterol combination was associated with an increase in trough FEV1 compared with fluticasone furoate-fluticasone propionate; however, observed differences may not be clinically significant. Studies comparing fluticasone furoate-vilanterol with fixed twice-daily ICS-LABA combinations are required.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Gustavo J. MD, Vicente MD, PhD,